Startseite>>Signaling Pathways>> GPCR/G protein>> CRFR>>R121919 (NBI30775)

R121919 (NBI30775)

Katalog-Nr.GC30792

R121919 (NBI30775) (NBI30775) ist ein potenter niedermolekularer CRF1-Rezeptorantagonist mit einem Ki von 2 bis 5 nM fÜr den CRF1-Rezeptor und einer Über 1000-fach schwÄcheren AktivitÄt am CRF2-Rezeptor, CRF-bindenden Protein oder 70 anderen Rezeptortypen .

Products are for research use only. Not for human use. We do not sell to patients.

R121919 (NBI30775) Chemische Struktur

Cas No.: 195055-03-9

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
169,00 $
Auf Lager
1mg
101,00 $
Auf Lager
5mg
202,00 $
Auf Lager
10mg
321,00 $
Auf Lager
25mg
644,00 $
Auf Lager
50mg
1.103,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

R121919 is a potent small-molecule CRF1 receptor antagonist with a Ki of 2 to 5 nM for the CRF1 receptor and over 1000-fold weaker activity at the CRF2 receptor, CRF-binding protein, or 70 other receptor types.

R121919 is a potent small-molecule CRF1 receptor antagonistwith high affinity for the CRF1 receptor (Ki=2-5 nM) and over 1000-fold weaker activity at the CRF2 receptor, CRF-binding protein, or 70 other receptor types[1].

R121919 reduces measures of both anxiety and depression in the depressed patients. R121919 dose dependently decreases adrenocorticopin hormone and corticosterone responses to restraint stress in rats. Peak plasma adrenocorticopin hormone and corticosterone concentrations at a dose of 10 mg/kg R121919 are 9 and 25%, respectively[1]. R121919 reduces levels of anxiety in mice with a steep dose-response curve. Molecules such as GR, MR, BAG-1 and AP-1 have been identified as some of the drug's intracellular targets[2].

[1]. Gutman DA, et al. The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. J Pharmacol Exp Ther. 2003 Feb;304(2):874-80. [2]. Post A, et al. Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919). Psychopharmacology (Berl). 2005 Jun;180(1):150-8.

Bewertungen

Review for R121919 (NBI30775)

Average Rating: 5 ★★★★★ (Based on Reviews and 7 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for R121919 (NBI30775)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.